A new trading day began on Friday, with Atyr Pharma Inc (NASDAQ: ATYR) stock price up 9.20% from the previous day of trading, before settling in for the closing price of $0.71. ATYR’s price has ranged from $0.68 to $7.29 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 34.28% over the past five years. Meanwhile, its annual earnings per share averaged 15.75%. With a float of $95.98 million, this company’s outstanding shares have now reached $97.99 million.
Atyr Pharma Inc (ATYR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Atyr Pharma Inc is 2.05%, while institutional ownership is 67.62%. The most recent insider transaction that took place on Mar 17 ’25, was worth 15,000. In this transaction Director of this company bought 3,750 shares at a rate of $4.00, taking the stock ownership to the 9,750 shares. Before that another transaction happened on Feb 04 ’25, when Company’s Chief Financial Officer sold 1,254 for $3.78, making the entire transaction worth $4,740. This insider now owns 31,763 shares in total.
Atyr Pharma Inc (ATYR) Performance Highlights and Predictions
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.23 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.75% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.08% during the next five years compared to 34.28% growth over the previous five years of trading.
Atyr Pharma Inc (NASDAQ: ATYR) Trading Performance Indicators
Here are Atyr Pharma Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.63.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit -0.18 in the next quarter and is forecasted to reach -0.59 in one year’s time.
Technical Analysis of Atyr Pharma Inc (ATYR)
Atyr Pharma Inc (NASDAQ: ATYR) saw its 5-day average volume 14.44 million, a positive change from its year-to-date volume of 4.73 million. As of the previous 9 days, the stock’s Stochastic %D was 11.79%.
During the past 100 days, Atyr Pharma Inc’s (ATYR) raw stochastic average was set at 1.42%, which indicates a significant decrease from 18.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0877 in the past 14 days, which was lower than the 0.3825 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.9581, while its 200-day Moving Average is $3.9603. Nevertheless, the first resistance level for the watch stands at $0.8074 in the near term. At $0.8396, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8893. If the price goes on to break the first support level at $0.7255, it is likely to go to the next support level at $0.6758. Assuming the price breaks the second support level, the third support level stands at $0.6436.
Atyr Pharma Inc (NASDAQ: ATYR) Key Stats
With a market capitalization of 75.96 million, the company has a total of 97,987K Shares Outstanding. Currently, annual sales are 240 K while annual income is -64,020 K. The company’s previous quarter sales were 0 K while its latest quarter income was -19,530 K.
